Simplified information request service established ~
~ Publication of nine trial summary documents ~
Wednesday, 1 September 2021
GSK has established an enhanced information service for former residents of mother and baby homes regarding trials that took place between 1934 and 1973 in response to the issues raised following the publication of the Commission of Investigation’s report.
This enhanced information service consists of:
- A more simplified information request service.
- The publication of trial summary documents for nine separate trials – vaccine trials A to G, as they are referred to in the Commission’s report, as well as two infant milk formula trials.
GSK recognises that many survivors are understandably seeking to access their personal information. The company has spent time reflecting on its response to the Commission’s report and has endeavoured to find a meaningful way to assist survivors and their families. GSK believes these measures undertaken to simplify the information request service and publish trial summary documents represents the most valuable way to support those seeking further transparency in relation to the trials.
Full details of how to access the information request service and the trial summary documents are now available on our website.
Information Request Service:
For some years GSK has provided an information service to survivors who request that a search of the records is performed to identify what, if any, personal information GSK holds about them. Demand for this service – known as a ‘subject access request’ – has increased since the publication of the Commission of Investigation’s report. To ensure the information service is as user-friendly as possible, GSK has worked to simplify the process and details of how to access it are available on our website.
GSK wants to ensure that survivors who believe they may have been a participant in a trial are aware they have a statutory right to submit an information request to the company in relation to their personal information.
It is important to note, however, that the records are not complete for every trial. While some of the individual clinical trial records do contain important identifying information such as names and dates of birth, this information is not available for all trials. This means it is not possible to verify the identity of every participant and part of the reason why GSK has also published trial summary documents with information about the development and, where applicable, the licensing history of the trial products.
Trial Summary Documents:
The trial summary documents are also available at www.gsk.ie/mother-and-baby-homes and contain information relating to nine separate trials – vaccine trials A to G, as they are referred to in the Commission’s report, and two infant milk formula trials.
The documentation has been collated from GSK’s archives in London as well as other published sources to evaluate, as far as possible, the history of the vaccine or milk products after their trials were conducted by researchers in mother and baby homes.
GSK would like to re-emphasise its sympathies to the women, children and families affected by the issues raised in the Commission’s report and sincerely hopes the work undertaken to enhance its information service and publish trial summaries will better support those searching for more information about their personal experience or that of a family member.